Michael Sweet

Michael Sweet is the director of preclinical study management and a study director at Veranex Preclinical Services – Atlanta, bringing 15 years of specialized expertise in GLP-compliant preclinical research. His extensive experience spans ECMO/VAD devices, interventional cardiovascular procedures, and structural heart models, establishing him as a leading authority in complex medical device evaluation. As a biomedical engineer and researcher, Michael integrates deep technical knowledge with hands-on expertise across multiple imaging modalities, including ultrasound, micro-CT, MRI, and CT. His proficiency in scientific data analysis, advanced imaging technologies, and cardiovascular study design, combined with his ability to translate complex findings into clear, actionable scientific documentation, makes him an invaluable asset to medical device developers seeking rigorous preclinical validation of their innovations.